PolarityTE, Inc. announced that its skin regeneration product, SkinTE™, has been named as a finalist in the Fierce Innovation Awards Life Science Edition 2018 in the Biotech Innovation category.
These awards, established by FierceBiotech and FiercePharma, recognize outstanding innovation that is transforming medicine. An expert panel of judges, comprised of industry leaders in the biotech field, review submissions to determine which companies and products demonstrate innovation that has the potential to make the greatest impact. Submissions are scored based on the following criteria: effectiveness, technical innovation, competitive advantage, financial impact and true innovation. The winner will be announced on December 13, 2018 with the publication of the Fierce Innovation Report – Life Sciences Edition 2018.
"We are honored that SkinTE has been named as a finalist in the Biotech Innovation category of the Fierce Innovation Awards. Though SkinTE has only been available to patients for less than a year, the selection as a finalist is credit to the impact it is having on patients and industry. We appreciate recognition of our work as we continue to deliver on the promise of regenerative medicine," said Denver M. Lough, MD, PhD, Chairman and Chief Executive Officer of PolarityTE.